Additionally, future research should aim to uncover the underlying mechanisms by which GATA3 and FOXA1 expression is altered in UTUC and how these alterations contribute to adverse clinical outcomes. Here, GATA3 is linked to renal pelvis/ureter urothelial carcinoma.